Detalhe da pesquisa
1.
Long-acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study.
Int Forum Allergy Rhinol
; 12(2): 147-159, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534410
2.
Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis.
Am J Rhinol Allergy
; 36(6): 733-740, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708181
3.
Impact of long-acting implantable LYR-210 corticosteroid matrices on quality of life of patients with chronic rhinosinusitis in the LANTERN study.
Int Forum Allergy Rhinol
; 13(9): 1821-1824, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36752990